Inventor · disambiguated record
Tai Wei Ly
Also filed as: LY TAI WEI
28 granted patents·5 pending applications·52 citations·filing 2004–2021
94Inventor score
Files withAXIKIN PHARMACEUTICALS INC14LY TAI WEI13ACTIMIS PHARMACEUTICALS INC33SM BIOTRON INC1METAGONE BIOTECH INC1
Top patents by PatentIndex Score
33 records- 0185US8916555B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·8 cites·50 claims
- 0282US8399456B22,5-disubstituted arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2010·Granted Mar 19, 2013·9 cites·41 claims
- 0382US8318747B22,5-disubstituted arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2010·Granted Nov 27, 2012·5 cites·23 claims
- 0477US8420639B2Arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2010·Granted Apr 16, 2013·5 cites·37 claims
- 0577US7750014B2Imidazo[1,2-C]pyrimidinylacetic acid derivativesACTIMIS PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·5 cites·13 claims
- 0676US8741894B2Arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2011·Granted Jun 3, 2014·4 cites·17 claims
- 0775US9156799B2Isotopically enriched arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Oct 13, 2015·2 cites·7 claims
- 0872US9187425B22,5-disubstituted arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Nov 17, 2015·1 cites·24 claims
- 0972US8563544B22,5-disubstituted arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2012·Granted Oct 22, 2013·1 cites·20 claims
- 1072US8541419B2Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonistsLY TAI WEI·Filed 2009·Granted Sep 24, 2013·1 cites·12 claims
- 1171US8999995B2Isotopically enriched arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2011·Granted Apr 7, 2015·2 cites·46 claims
- 1270US9365556B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Jun 14, 2016·1 cites·45 claims
- 1370US7812160B2Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2ACTIMIS PHARMACEUTICALS INC·Filed 2004·Granted Oct 12, 2010·6 cites·14 claims
- 1466US8669247B22,5-disubstituted arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2013·Granted Mar 11, 2014·1 cites·40 claims
- 1566US7960393B2Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2ACTIMIS PHARMACEUTICALS INC·Filed 2010·Granted Jun 14, 2011·1 cites·14 claims
- 1660US9382237B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted Jul 5, 2016·0 cites·53 claims
- 1760US9346792B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted May 24, 2016·0 cites·54 claims
- 1857US8278310B2Amine salts of a CRTH2 antagonistLY TAI WEI·Filed 2008·Granted Oct 2, 2012·0 cites·39 claims
- 1953US9540351B2Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·0 cites·44 claims
- 2053US2022098169A1Antiviral agentsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 2151US8507005B2Particulates of a CRTH2 antagonistLY TAI WEI·Filed 2008·Granted Aug 13, 2013·0 cites·11 claims
- 2251US2016031841A12,5-disubstituted arylsulfonamide ccr3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2349US9730914B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·0 cites·37 claims
- 2449US9546163B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2015·Granted Jan 17, 2017·0 cites·41 claims
- 2549US2014221428A1Arylsulfonamide ccr3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2648US8658642B2Arylsulfonamide CCR3 antagonistsLY TAI WEI·Filed 2013·Granted Feb 25, 2014·0 cites·36 claims
- 2747US11304930B2Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and uses thereofMETAGONE BIOTECH INC·Filed 2019·Granted Apr 19, 2022·0 cites·21 claims
- 2847US8324229B2Alkylthio pyrimidines as CRTH2 antagonistsLY TAI WEI·Filed 2008·Granted Dec 4, 2012·0 cites·42 claims
- 2947US8314116B22-S-benzyl substituted pyrimidines as CRTH2 antagonistsLY TAI WEI·Filed 2008·Granted Nov 20, 2012·0 cites·37 claims
- 3044US2017079954A1Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3143US9637460B2Isotopically enriched arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2015·Granted May 2, 2017·0 cites·47 claims
- 3239US2012088769A1Salts of arylsulfonamide ccr3 antagonistsLY TAI WEI·Filed 2011·Application pending·0 cites
- 3329US11332476B2Fms-like tyrosine kinase inhibitors3SM BIOTRON INC·Filed 2018·Granted May 17, 2022·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Tai Wei Ly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →